CMCintia Rodrigues Marques

Cintia Rodrigues Marques

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cintia Rodrigues Marques has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic odyssey and healthcare access challenges in Rett Syndrome: perspectives from Brazilian families

    by Gabriella Almeida Santos de Santana, Lindinês de Jesus Sousa, Maria José Souza Silva, Narciso DiLorenzo Machado Dias, Gabriela Garcia de Carvalho Laguna, Larissa Alves Fernandes, Cintia Rodrigues Marques, Patrícia da Silva Oliveira

    Objective: To analyze the challenges in the diagnosis and care of Rett Syndrome based on the experiences of caregivers in Brazil. Methods: This study employed a convergent mixed-methods approach. Data were collected from 14 primary caregivers of children with genetically confirmed Rett Syndrome. Data collection included thematic analysis of semi-structured interviews and descriptive statistics from sociodemographic questionnaires. Results: The mean diagnostic delay was 3.6 years (standard deviation — SD=1.4 years; range, 2–6 years), with a median of 3.5 years. The distribution was assessed and deemed suitable for reporting the mean. Most cases (92.8%) were initially attributed to autism spectrum disorder. The main barriers were limited knowledge among professionals (78.6%), delays in genetic testing (92.8%), and difficulties accessing therapies. Caregivers (12 mothers, 2 fathers; mean age, 38.0 years [SD, 4.1]; 57.1% with a college degree) reported a significant physical and emotional burden, with 92.8% providing full-time care without institutional support. The qualitative analysis revealed four themes: the diagnostic journey, the battle for therapy, the impact on family life, and the burden of care. Conclusions: Diagnosis and care are hindered by knowledge gaps, systemic inefficiencies, and limited support. The findings highlight the need to improve education on rare diseases, streamline access to genetic testing and therapies, and implement support programs for caregivers.

  • Open Access

    Prevalence of Helicobacter pylori cagA virulence factor and validation of serological tests in a population from Northeastern Brazil

    by A.C. Freitas, I.A. Santana-Santos, I.S. Lima, D.K. Queiroz-Santos-Trindade, L.F. Sandes, T.M.L. Correia, D.B. Almeida, M.A. Lescano-Lescano, L.C. Santana, C.A. Figueiredo, et al.

    Helicobacter pylori is an infectious agent linked to significant gastric pathologies, which makes it a public health concern. The enzyme-linked immunosorbent assay (ELISA) is widely used for epidemiological studies and for investigating virulence factors like the cagA gene. Due to the varying antigenic profiles of bacterial strains across different populations, the local validation of serological tests is essential. This study aimed to evaluate the performance of two commercial serological tests - the MyBiosource HP-CagA-IgG ELISA kit and the Sunlong Human IgG (CagA-IgG) ELISA kit - in detecting the cagA virulence factor and to assess its prevalence in bacterial isolates from a population in the southwest region of Bahia. A total of 88 individuals were enrolled, and 34 tested positive for the cagA factor via real-time PCR. After establishing customized cutoff points, the MyBiosource kit demonstrated a sensitivity of 55.88%, specificity of 50%, and accuracy of 52.22%, while the Sunlong kit showed a sensitivity of 70.59%, specificity of 60%, and accuracy of 64.29%. Despite these results, neither test met satisfactory performance standards, with sensitivity below 75% and specificity ranging from 50 to 60%. The overall prevalence of H. pylori infection was 56.8%, with a cagA prevalence of 68% among positive cases. Further investigations using additional commercial tests are recommended to enhance diagnostic outcomes for this population.